504 related articles for article (PubMed ID: 34814947)
21. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
22. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
23. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
Hughes CD; Choi ML; Ryten M; Hopkins L; Drews A; Botía JA; Iljina M; Rodrigues M; Gagliano SA; Gandhi S; Bryant C; Klenerman D
Acta Neuropathol; 2019 Jan; 137(1):103-120. PubMed ID: 30225556
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
25. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
26. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease.
Baizabal-Carvallo JF; Alonso-Juarez M
Neuroscience; 2020 Apr; 432():160-173. PubMed ID: 32112917
[TBL] [Abstract][Full Text] [Related]
27. Toll-like Receptor 4 Is Upregulated in Parkinson's Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology.
Conte C; Ingrassia A; Breve J; Bol JJ; Timmermans-Huisman E; van Dam AM; Beccari T; van de Berg WDJ
Cells; 2023 May; 12(10):. PubMed ID: 37408202
[TBL] [Abstract][Full Text] [Related]
28. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
Kim C; Spencer B; Rockenstein E; Yamakado H; Mante M; Adame A; Fields JA; Masliah D; Iba M; Lee HJ; Rissman RA; Lee SJ; Masliah E
Mol Neurodegener; 2018 Aug; 13(1):43. PubMed ID: 30092810
[TBL] [Abstract][Full Text] [Related]
31. A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology.
Chedid J; Labrador-Garrido A; Zhong S; Gao J; Zhao Y; Perera G; Kim WS; Halliday GM; Dzamko N
J Biol Chem; 2022 Aug; 298(8):102260. PubMed ID: 35841928
[TBL] [Abstract][Full Text] [Related]
32. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis.
Chen SJ; Lin CH
J Biomed Sci; 2022 Jul; 29(1):54. PubMed ID: 35897024
[TBL] [Abstract][Full Text] [Related]
33. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
34. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
35. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
Anis E; Xie A; Brundin L; Brundin P
Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
[TBL] [Abstract][Full Text] [Related]
36. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
Conte C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment.
Salim S; Ahmad F; Banu A; Mohammad F
J Adv Res; 2023 Aug; 50():83-105. PubMed ID: 36332796
[TBL] [Abstract][Full Text] [Related]
38. Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases.
Pan I; Issac PK; Rahman MM; Guru A; Arockiaraj J
Mol Neurobiol; 2023 Oct; ():. PubMed ID: 37851313
[TBL] [Abstract][Full Text] [Related]
39. Involvement of Abnormal p-α-syn Accumulation and TLR2-Mediated Inflammation of Schwann Cells in Enteric Autonomic Nerve Dysfunction of Parkinson's Disease: an Animal Model Study.
Jiang W; Cheng Y; Wang Y; Wu J; Rong Z; Sun L; Zhou Y; Zhang K
Mol Neurobiol; 2023 Aug; 60(8):4738-4752. PubMed ID: 37148524
[TBL] [Abstract][Full Text] [Related]
40. Parkinson's Disease and Gut Microbiota.
Hirayama M; Ohno K
Ann Nutr Metab; 2021; 77 Suppl 2():28-35. PubMed ID: 34500451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
